A standing rule for this whole program, stated once and applied on every page below: these capabilities exist to prevent diversion, identity theft, misidentification and preventable overdose, and to give clinicians and agencies the clinical context that count-based analysis lacks. They do not exist to police people who are in pain. Where a capability could be turned to that use, the page says so.

Getting the medication to the person

• Pharmaceutical delivery partnerships — closing therapy gaps for people without reliable transportation, and removing the informal courier who is a diversion point.
• Safe storage and rescue medication — naloxone in the home and a lockable place to keep controlled medication.

Knowing who is receiving it

• Biometric cross-validation — palm-vein or 3D facial confirmation at the point of transfer.
• DNALock — a buccal-swab identity anchor for the specimen chain.
• Custodial toxicology — chain-of-custody collection so a result can never be attributed to the wrong person.

Understanding the clinical picture

• ProviderSynch — a pull API that returns a health-history summary when a prescription is transmitted.
• EMR and LIS integration — diagnosis coding, laboratory results, chronic care management and remote therapeutic monitoring (RTM) in one view.
• Metabolic determination — identifying pharmacokinetic outliers instead of marginalizing them.
• MedimetRx psychometrics — validated behavioral health screening, scored against normative data and against the person’s own history.
• Remote patient monitoring — consented between-visit signal, with early identification of depression and suicidality.

Assessing risk honestly

• Risk assessment — medical, social and family history, per the federal Task Force recommendation.
• Social determinants verification — confirming circumstances so that support is matched to actual need.
• AI integrated rule discovery — the simplest model that explains the data, deliberately avoiding black-box complexification.

Watching the supply, not the patient

• Drug-supply signal analysis — what substances are circulating in a region, under what street names.
• Population-based emerging threat analysis — detecting a change in the local supply early enough to warn people.
• Integrated real-time overdose registry — a shared, current picture of overdose events across an agency’s jurisdiction.

Frequently asked questions

What are some ways to prevent the opioid crisis?

IntellaRx works on five fronts: getting the medication to the person, knowing who receives it, understanding the clinical picture, assessing risk honestly, and watching the drug supply rather than the patient. Each one targets diversion, identity theft, misidentification or preventable overdose, and gives clinicians and agencies the clinical context that count-based analysis lacks. None of it exists to police people who are in pain.

What are examples of prevention programs?

Examples from this program include delivery partnerships that close therapy gaps and remove the informal courier, naloxone and a lockable place for controlled medication in the home, palm-vein or 3D facial confirmation at the point of transfer, validated behavioral health screening, and an integrated real-time overdose registry that gives an agency a current picture of overdose events across its jurisdiction. Nothing here is designed to build cases against patients.